PACIRA PHARMACEUTICALS INC's ticker is PCRX and the CUSIP is 695127100. A total of 261 filers reported holding PACIRA PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is 0.66 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $797,680 | -23.4% | 26,000 | 0.0% | 0.15% | -20.8% |
| Q2 2023 | $1,041,820 | -45.5% | 26,000 | -44.4% | 0.19% | -36.0% |
| Q1 2023 | $1,909,908 | +5.7% | 46,800 | 0.0% | 0.30% | +2.0% |
| Q4 2022 | $1,806,948 | +477.3% | 46,800 | +800.0% | 0.29% | +326.1% |
| Q4 2021 | $313,000 | -9.8% | 5,200 | -16.1% | 0.07% | -9.2% |
| Q3 2021 | $347,000 | -53.9% | 6,200 | -50.0% | 0.08% | -51.3% |
| Q2 2021 | $752,000 | – | 12,400 | – | 0.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Gagnon Advisors, LLC | 251,140 | $19,167,000 | 8.83% |
| GAGNON SECURITIES LLC | 610,933 | $46,626,000 | 7.60% |
| Tamarack Advisers, LP | 205,000 | $15,646,000 | 7.40% |
| Spyglass Capital Management LLC | 1,871,040 | $142,798,000 | 4.88% |
| Lisanti Capital Growth, LLC | 302,413 | $23,080,000 | 2.59% |
| Rock Springs Capital Management LP | 1,000,000 | $76,320,000 | 1.92% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 208,197 | $15,890,000 | 1.76% |
| JABODON PT CO | 49,052 | $3,744,000 | 1.70% |
| Zweig-DiMenna Associates LLC | 166,675 | $12,721,000 | 1.70% |
| NEUMEIER POMA INVESTMENT COUNSEL LLC | 317,425 | $24,226,000 | 1.63% |